CXCR2 and neoplasm: Given the dramatic effect of CSF1R inhibition as a single agent compared to our previous work on CXCR2 inhibition where efficacy in late-stage tumors was only observed in combination with anti-checkpoint inhibition (Steele et al., 2016), we wanted to compare the effect of these inhibitors on tumor gene expression.